Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Promega Corporation’s GoTaq® Probe 1-Step RT-qPCR System is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. The Promega tool is an approved master mix option for the CDC’s 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel that is available through the CDC’s Emergency Use Authorization (EUA). In a letter dated March 30, 2020, the FDA granted approval of an amendment to the CDC’s diagnostic COVID-19 assay that includes acknowledgement that Promega master mix is an approved amplification reagent for laboratories using the CDC’s assay. The assay protocol is used by hundreds of public health labs and clinical testing labs in the United States and is referenced by thousands of labs around the world.

Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel

Image credit: Promega

Thanks to the CDC acting quickly to make product additions to their protocol, labs now have one more CDC-approved master mix when performing the 2019-Novel Coronavirus Real-Time RT-PCR Diagnostic Panel. The Promega GoTaq® Probe 1-Step RT-qPCR System expands the testing capacity in the US by being another option for labs to use for the amplification process in the CDC’s testing protocol.”

Heather Tomlinson, Promega Director of Clinical Diagnostics

The GoTaq® Probe 1-Step RT-qPCR System is a ready-to-use master mix of optimized components for robust RT-qPCR using hydrolysis probes. Promega supplies automation, sample extraction and diagnostic reagents around the world, and began scaling up manufacturing in January to address unprecedented demand for COVID-19 related tools. Promega reagents are also currently incorporated in 15 COVID-19 diagnostic tests produced by other global diagnostic manufacturers.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Promega Corporation. (2020, May 12). Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel. News-Medical. Retrieved on September 30, 2020 from https://www.news-medical.net/news/20200406/Promega-GoTaq-Probe-1-Step-RT-qPCR-System-approved-for-use-in-CDCe28099s-COVID-19-Emergency-Use-Authorization-diagnostic-panel.aspx.

  • MLA

    Promega Corporation. "Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel". News-Medical. 30 September 2020. <https://www.news-medical.net/news/20200406/Promega-GoTaq-Probe-1-Step-RT-qPCR-System-approved-for-use-in-CDCe28099s-COVID-19-Emergency-Use-Authorization-diagnostic-panel.aspx>.

  • Chicago

    Promega Corporation. "Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel". News-Medical. https://www.news-medical.net/news/20200406/Promega-GoTaq-Probe-1-Step-RT-qPCR-System-approved-for-use-in-CDCe28099s-COVID-19-Emergency-Use-Authorization-diagnostic-panel.aspx. (accessed September 30, 2020).

  • Harvard

    Promega Corporation. 2020. Promega GoTaq Probe 1-Step RT-qPCR System approved for use in CDC’s COVID-19 Emergency Use Authorization diagnostic panel. News-Medical, viewed 30 September 2020, https://www.news-medical.net/news/20200406/Promega-GoTaq-Probe-1-Step-RT-qPCR-System-approved-for-use-in-CDCe28099s-COVID-19-Emergency-Use-Authorization-diagnostic-panel.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
You might also like... ×
Promega and MilliporeSigma sign license agreement to expand the potential of CRISPR